SEC Form 4 · accession 0001209191-15-060550
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl Goldfischer
Director
Period of report
Jul 8, 2015
Accepted (ET)
Jul 10, 2015 · 7:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $22.78 | Jul 8, 2015 | A | 7,333 | A | — | Jul 7, 2025 | Common Stock | 7,333 | 7,333 | D |
Explanation of responses
- F1This option was granted on July 8, 2015, pursuant to the Company's 2013 Stock Incentive Plan with respect to 7,333 shares of Common Stock and vests in full on July 8, 2016 and, in the event of a change in control of the Company, the vesting will accelerate in full.
Remarks
Exhibit List Exhibit 24 - Confirming Statement